Author Search Results

1

Loading...

WHAT ADVERSE REACTIONS TO BIOLOGICAL AGENTS ARE PARADOXICAL?

by Yu. V. Muravyev
Published 2018-09-01

Get full text

Artigo

2

Loading...

WHY IS THE STUDY OF THE COMPLEX SAFETY OF CELECOXIB FOR ARTHRITIS, WHICH IS CALLED PRECISION, LAST BUT NOT LEAST?

by Yu. V. Muravyev
Published 2017-07-01

Get full text

Artigo

3

Loading...

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?

by Yu. V. Muravyev
Published 2017-09-01

Get full text

Artigo

4

Loading...

EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS

by Yu. V. Muravyev
Published 2018-07-01

Get full text

Artigo

5

Loading...

DIAGNOSTIC AND CLASSIFICATION CRITERIA IN RHEUMATOLOGY: WHEN SHOULD THE CRITERIA BE USED AND HOW DO THEY DIFFER?

by Yu. V. Muravyev
Published 2017-03-01

Get full text

Artigo

6

Loading...

NEW POSSIBILITIES FOR MONITORING METHOTREXATE EFFICACY IN RHEUMATOID ARTHRITIS

by Yu. V. Muravyev
Published 2015-09-01

Get full text

Artigo

7

Loading...

Rheumatoid arthritis classification criteria: debatable problems

by Yu. V. Muravyev, A. S. Misiyuk
Published 2019-01-01

Get full text

Artigo

8

Loading...

On the terms «rheumatology» and «rheumatic diseases» (regarding Sh. Erdes's article «Definition of the term «rheumatology»: do we need this and how do the EULAR and the ACR look at...

by Yu. V. Muravyev, L. A. Muravyeva
Published 2019-07-01

Get full text

Artigo

9

Loading...

DISCUSSION IDEAS ABOUT MEDICINE AMBIGUITIES

by Yu. V. Muravyev, L. A. Muravyev
Published 2017-10-01

Get full text

Artigo

10

Loading...

The evolution of discussion ideas on drug-induced disease

by Yu. V. Muravyev, L. A. Muravyeva
Published 2016-10-01

Get full text

Artigo

11

Loading...

ADULT-ONSET STILL'S DISEASE TODAY

by Yu. V. Muravyev, V. V. Lebedeva
Published 2017-07-01

Get full text

Artigo

12

Loading...

WHAT TO DO WITH A VARIETY OF TERMS THAT REFLECT THE HARM OF DRUGS?

by Yu. V. Muravyev, L. A. Muravyeva
Published 2017-04-01

Get full text

Artigo

13

Loading...

POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS

by Yu. V. Muravyev, O. R. Bobkova
Published 2018-11-01

Get full text

Artigo

14

Loading...

XXI century: changes in the Erice Declaration on drug safety

by Yu. V. Muravyev, L. A. Muravyeva
Published 2019-05-01

Get full text

Artigo

15

Loading...

CHARACTERISTICS OF ADULT-ONSET STILL’S DISEASE IN THE 21ST CENTURY

by V. V. Lebedeva, Yu. V. Muravyev
Published 2018-09-01

Get full text

Artigo

16

Loading...

TARDY IDEAS ON THE USE OF BIOLOGICAL AGENTS IN RHEUMATIC DISEASES

by Yu. V. Muravyev, L. A. Muravyeva
Published 2016-07-01

Get full text

Artigo

17

Loading...

WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?

by Yu. V. Muravyev, E. L. Nasonov
Published 2017-03-01

Get full text

Artigo

18

Loading...

DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE

by Yu. V. Muravyev, L. A. Muravyeva
Published 2015-09-01

Get full text

Artigo

19

Loading...

ChTO DELAT'', ESLI V PERIOD LEChENIYa INGIBITORAMI FAKTORA NEKROZA OPUKhOLI α VOZNIK PSORIAZ?

by Yu. V. Muravyev, I. A. Doroshkevich
Published 2011-06-01

Get full text

Artigo

20

Loading...

The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis

by Yu. V. Muravyev, L. A. Muravyeva
Published 2018-09-01

Get full text

Artigo

Narrow Search